Skip to main content

IVERIC bio, Inc.

ISEEDelisted Jul 11, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001410939

IVERIC bio, Inc. was delisted on Jul 11, 2023; its insiders filed their last Form 4 on Jul 13, 2023; 256 institutions reported holding it in 13F filings for Q2 2023, worth $5.33B in total; Soros Fund Management was the only superinvestor holding it.

Holders of 5% or more of ISEE

Holders whose latest Schedule 13D or 13G filing reports 5% or more of IVERIC bio, Inc., largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of IVERIC bio, Inc. on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

29 Schedule 13D and 13G filings on IVERIC bio, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on ISEE
Filed (ET)FilerFormStakeChangeEvent dateFiling
Feb 14, 2023Vivo Capital IX, LLC13G/AOld format–––SEC
Feb 14, 2023Perceptive Advisors LLC13G/AOld format–––SEC
Feb 14, 2023Deep Track Capital, LP13G/AOld format–––SEC
Feb 14, 2023Avidity Partners Management LP13G/AOld format–––SEC
Feb 14, 2023RTW Investments, LP13G/AOld format–––SEC
Feb 14, 2023Avoro Capital Advisors LLC13G/AOld format–––SEC
Feb 10, 2023Flynn James E13G/AOld format–––SEC
Feb 9, 2023Vanguard Group Inc13GOld format–New–SEC
Feb 3, 2023State Street Corp13G/AOld format–––SEC
Jan 31, 20231:58 PM ETBlackRock Inc.13G/AOld format–––SEC
Oct 4, 2022Flynn James E13GOld format–––SEC
Sep 16, 2022Deep Track Capital, LP13GOld format–New–SEC
Feb 15, 2022Perceptive Advisors LLC13G/AOld format–––SEC
Feb 14, 2022Avidity Partners Management LP13G/AOld format–––SEC
Feb 11, 2022Vivo Capital IX, LLC13G/AOld format–––SEC
Feb 11, 2022Flynn James E13G/AOld format–––SEC
Feb 11, 2022State Street Corp13GOld format–New–SEC
Feb 2, 20227:11 PM ETBlackRock Inc.13G/AOld format–––SEC
Oct 25, 2021Avidity Partners Management LP13GOld format–New–SEC
Feb 17, 2021Consonance Capital Management LP13G/AOld format–––SEC
Feb 16, 2021Perceptive Advisors LLC13G/AOld format–––SEC
Feb 16, 2021Tamarack Advisers, LP13G/AOld format–––SEC
Feb 16, 2021Consonance Capital Management LP13G/AOld format–––SEC
Feb 12, 2021RTW Investments, LP13G/AOld format–––SEC
Feb 12, 2021Flynn James E13G/AOld format–––SEC
Feb 12, 2021Stonepine Capital Management, LLC13G/AOld format–––SEC
Feb 12, 2021Avoro Capital Advisors LLC13GOld format–New–SEC
Feb 10, 2021BML Investment Partners, L.P.13G/AOld format–––SEC
Feb 2, 20213:13 PM ETBlackRock Inc.13GOld format–New–SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell IVERIC bio, Inc. shares.

No Form 144 notices for IVERIC bio, Inc. are on file.